Changeflow GovPing Pharma & Drug Safety EPO Patent EP3356393A1: Chimeric Proteins for E...
Routine Notice Added Final

EPO Patent EP3356393A1: Chimeric Proteins for Extracellular Domains

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Peptides (C07K)
Published March 11th, 2026
Detected March 25th, 2026
Email

Summary

The European Patent Office has published patent application EP3356393A1 concerning chimeric proteins for adjoining extracellular domains. The patent, filed by Kopfkino IP, LLC, details compositions and methods related to these protein structures.

What changed

This document is a publication of a European patent application (EP3356393A1) by Kopfkino IP, LLC, titled 'Compositions and Methods for Adjoining Type I and Type II Extracellular Domains as Heterologous Chimeric Proteins'. The publication date is March 11, 2026. The patent covers specific chimeric protein structures and their applications, primarily within the biotechnology and pharmaceutical sectors.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it establishes intellectual property rights for the applicant and may influence future research and development activities in the field of protein engineering and therapeutics. Companies operating in the pharmaceutical and biotechnology sectors should be aware of this patent's existence as it pertains to their research and product development strategies.

Source document (simplified)

← EPO Patent Bulletin

COMPOSITIONS AND METHODS FOR ADJOINING TYPE I AND TYPE II EXTRACELLULAR DOMAINS AS HETEROLOGOUS CHIMERIC PROTEINS

Publication EP3356393A1 Kind: A1 Mar 11, 2026

Applicants

Kopfkino IP, LLC

Inventors

SCHREIBER, Taylor, FROMM, George, DE SILVA, Suresh, SCHILLING, Neal

IPC Classifications

C07K 14/525 20060101AFI20190701BHEP C07K 14/705 20060101ALI20190701BHEP C12N 7/00 20060101ALI20190701BHEP C12N 15/85 20060101ALI20190701BHEP A61K 38/17 20060101ALI20190701BHEP A61K 38/19 20060101ALI20190701BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Compositions and Methods for Adjoining Type I and Type II Extracellular Domains as Heterologous Chimeric Proteins

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3356393A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Biotechnology Research
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.